From Genes to Brain: Understanding Brain Development in Neurogenetic Disorders Using Neuroimaging Techniques

Child and Adolescent Psychiatric Clinics of North America

Volumn 16, Issue 3, 2007, Pages 557-579

  Schaer, Marie ^a,b   Eliez, Stephan ^a,c  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b EPFL   (Switzerland)

^c UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; BRAIN ATROPHY; BRAIN DEVELOPMENT; BRAIN REGION; CLINICAL FEATURE; COGNITION; DEMENTIA; DOWN SYNDROME; FRAGILE X SYNDROME; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC DISORDER; GENETIC POLYMORPHISM; HUMAN; NEWBORN PERIOD; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TEMPORAL LOBE; VELOCARDIOFACIAL SYNDROME;

BRAIN; DIGEORGE SYNDROME; FRAGILE X SYNDROME; HUMANS; MAGNETIC RESONANCE IMAGING; MENTAL DISORDERS; MOLECULAR BIOLOGY;

EID: 34249951021     PISSN: 10564993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chc.2007.02.002     Document Type: Review

References (132)

1. Pfefferbaum A., Mathalon D.H., Sullivan E.V., et al. A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood. Arch Neurol 51 9 (1994) 874-887
2. Giedd J.N., Blumenthal J., Jeffries N.O., et al. Brain development during childhood and adolescence: a longitudinal MRI study. Nat Neurosci 2 10 (1999) 861-863
3. Holland B.A., Haas D.K., Norman D., et al. MRI of normal brain maturation. AJNR Am J Neuroradiol 7 2 (1986) 201-208
4. Toga A.W., Thompson P.M., and Sowell E.R. Mapping brain maturation. Trends Neurosci 29 3 (2006) 148-159
5. Shaw P., Greenstein D., Lerch J., et al. Intellectual ability and cortical development in children and adolescents. Nature 440 7084 (2006) 676-679
6. Reiss A.L., Eliez S., Schmitt J.E., et al. Brain imaging in neurogenetic conditions: realizing the potential of behavioral neurogenetics research. Ment Retard Dev Disabil Res Rev 6 3 (2000) 186-197
7. Baumgardner T.L., Green K.E., and Reiss A.L. A behavioral neurogenetics approach to developmental disabilities: gene-brain-behavior associations. Curr Opin Neurol 7 2 (1994) 172-178
8. Mann D.M. The pathological association between Down syndrome and Alzheimer disease. Mech Ageing Dev 43 2 (1988) 99-136
9. Murphy K.C., and Owen M.J. Velo-cardio-facial syndrome: a model for understanding the genetics and pathogenesis of schizophrenia. Br J Psychiatry 179 (2001) 397-402
10. Hagerman R.J., Ono M.Y., and Hagerman P.J. Recent advances in fragile X: a model for autism and neurodegeneration. Curr Opin Psychiatry 18 5 (2005) 490-496
11. Jernigan T.L., and Bellugi U. Anomalous brain morphology on magnetic resonance images in Williams syndrome and Down syndrome. Arch Neurol 47 5 (1990) 529-533
12. Jernigan T.L., Bellugi U., Sowell E., et al. Cerebral morphologic distinctions between Williams and Down syndromes. Arch Neurol 50 2 (1993) 186-191
13. Kates W.R., Folley B.S., Lanham D.C., et al. Cerebral growth in fragile X syndrome: review and comparison with Down syndrome. Microsc Res Tech 57 3 (2002) 159-167
14. Wang P.P., Doherty S., Hesselink J.R., et al. Callosal morphology concurs with neurobehavioral and neuropathological findings in two neurodevelopmental disorders. Arch Neurol 49 4 (1992) 407-411
15. Reiss A.L., Abrams M.T., Greenlaw R., et al. Neurodevelopmental effects of the FMR-1 full mutation in humans. Nat Med 1 2 (1995) 159-167
16. Murphy K.C., Jones L.A., and Owen M.J. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 56 10 (1999) 940-945
17. Brunberg J.A., Jacquemont S., Hagerman R.J., et al. Fragile X premutation carriers: characteristic MR imaging findings of adult male patients with progressive cerebellar and cognitive dysfunction. AJNR Am J Neuroradiol 23 10 (2002) 1757-1766
18. Jacquemont S., Hagerman R.J., Leehey M., et al. Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates. Am J Hum Genet 72 4 (2003) 869-878
19. Andreasen N.C., Rajarethinam R., Cizadlo T., et al. Automatic atlas-based volume estimation of human brain regions from MR images. J Comput Assist Tomogr 20 1 (1996) 98-106
20. Bokde A.L., Teipel S.J., Zebuhr Y., et al. A new rapid landmark-based regional MRI segmentation method of the brain. J Neurol Sci 194 1 (2002) 35-40
21. Kates W.R., Abrams M.T., Kaufmann W.E., et al. Reliability and validity of MRI measurement of the amygdala and hippocampus in children with fragile X syndrome. Psychiatry Res 75 1 (1997) 31-48
22. Ashburner J., and Friston K.J. Voxel-based morphometry: the methods. Neuroimage 11 6 Pt 1 (2000) 805-821
23. Thompson P.M., Hayashi K.M., Sowell E.R., et al. Mapping cortical change in Alzheimer's disease, brain development, and schizophrenia. Neuroimage 23 Suppl 1 (2004) S2-S18
24. Fischl B., and Dale A.M. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci USA 97 20 (2000) 11050-11055
25. Fischl B., Sereno M.I., Tootell R.B., et al. High-resolution intersubject averaging and a coordinate system for the cortical surface. Hum Brain Mapp 8 4 (1999) 272-284
26. Thompson P.M., Hayashi K.M., de Zubicaray G., et al. Dynamics of gray matter loss in Alzheimer's disease. J Neurosci 23 3 (2003) 994-1005
27. Zilles K., Armstrong E., Schleicher A., et al. The human pattern of gyrification in the cerebral cortex. Anat Embryol (Berl) 179 2 (1988) 173-179
28. Mangin J.F., Riviere D., Cachia A., et al. A framework to study the cortical folding patterns. Neuroimage 23 Suppl 1 (2004) S129-S138
29. White T., Andreasen N.C., and Nopoulos P. Brain volumes and surface morphology in monozygotic twins. Cereb Cortex 12 5 (2002) 486-493
30. Luders E., Thompson P.M., Narr K.L., et al. A curvature-based approach to estimate local gyrification on the cortical surface. Neuroimage 29 4 (2006) 1224-1230
31. Pierpaoli C., Jezzard P., Basser P.J., et al. Diffusion tensor MR imaging of the human brain. Radiology 201 3 (1996) 637-648
32. Mukherjee P., Miller J.H., Shimony J.S., et al. Diffusion-tensor MR imaging of gray and white matter development during normal human brain maturation. AJNR Am J Neuroradiol 23 9 (2002) 1445-1456
33. Barnea-Goraly N., Eliez S., Hedeus M., et al. White matter tract alterations in fragile X syndrome: preliminary evidence from diffusion tensor imaging. Am J Med Genet B Neuropsychiatr Genet 118 1 (2003) 81-88
34. Barnea-Goraly N., Menon V., Krasnow B., et al. Investigation of white matter structure in velocardiofacial syndrome: a diffusion tensor imaging study. Am J Psychiatry 160 10 (2003) 1863-1869
35. Mori S., Kaufmann W.E., Davatzikos C., et al. Imaging cortical association tracts in the human brain using diffusion-tensor-based axonal tracking. Magn Reson Med 47 2 (2002) 215-223
36. Hagmann P., Thiran J.P., Jonasson L., et al. DTI mapping of human brain connectivity: statistical fibre tracking and virtual dissection. Neuroimage 19 3 (2003) 545-554
37. Molko N., Cohen L., Mangin J.F., et al. Visualizing the neural bases of a disconnection syndrome with diffusion tensor imaging. J Cogn Neurosci 14 4 (2002) 629-636
38. Thase M.E. Longevity and mortality in Down's syndrome. J Ment Defic Res 26 Pt 3 (1982) 177-192
39. Schmidt-Sidor B., Wisniewski K.E., Shepard T.H., et al. Brain growth in Down syndrome subjects 15 to 22 weeks of gestational age and birth to 60 months. Clin Neuropathol 9 4 (1990) 181-190
40. Pinter J.D., Eliez S., Schmitt J.E., et al. Neuroanatomy of Down's syndrome: a high-resolution MRI study. Am J Psychiatry 158 10 (2001) 1659-1665
41. Kesslak J.P., Nagata S.F., Lott I., et al. Magnetic resonance imaging analysis of age-related changes in the brains of individuals with Down's syndrome. Neurology 44 6 (1994) 1039-1045
42. Raz N., Torres I.J., Briggs S.D., et al. Selective neuroanatomic abnormalities in Down's syndrome and their cognitive correlates: evidence from MRI morphometry. Neurology 45 2 (1995) 356-366
43. Ieshima A., Kisa T., Yoshino K., et al. A morphometric CT study of Down's syndrome showing small posterior fossa and calcification of basal ganglia. Neuroradiology 26 6 (1984) 493-498
44. Wisniewski K.E., Laure-Kamionowska M., and Wisniewski H.M. Evidence of arrest of neurogenesis and synaptogenesis in brains of patients with Down's syndrome. N Engl J Med 311 18 (1984) 1187-1188
45. Wisniewski K.E., and Schmidt-Sidor B. Postnatal delay of myelin formation in brains from Down syndrome infants and children. Clin Neuropathol 8 2 (1989) 55-62
46. Nadel L. Down's syndrome: a genetic disorder in biobehavioral perspective. Genes Brain Behav 2 3 (2003) 156-166
47. Ohr P.S., and Fagen J.W. Conditioning and long-term memory in three-month-old infants with Down syndrome. Am J Ment Retard 96 2 (1991) 151-162
48. Ohr P.S., and Fagen J.W. Contingency learning in 9-month-old infants with Down syndrome. Am J Ment Retard 99 1 (1994) 74-84
49. Dambska M., and Laure-Kamionowska M. Myelination as a parameter of normal and retarded brain maturation. Brain Dev 12 2 (1990) 214-220
50. Pinter J.D., Brown W.E., Eliez S., et al. Amygdala and hippocampal volumes in children with Down syndrome: a high-resolution MRI study. Neurology 56 7 (2001) 972-974
51. Aylward E.H., Habbak R., Warren A.C., et al. Cerebellar volume in adults with Down syndrome. Arch Neurol 54 2 (1997) 209-212
52. Koop M., Rilling G., Herrmann A., et al. Volumetric development of the fetal telencephalon, cerebral cortex, diencephalon, and rhombencephalon, including the cerebellum in man. Bibl Anat 28 (1986) 53-78
53. Shapiro B.L. Developmental instability of the cerebellum and its relevance to Down syndrome. J Neural Transm Suppl 61 (2001) 11-34
54. Teipel S.J., Schapiro M.B., Alexander G.E., et al. Relation of corpus callosum and hippocampal size to age in nondemented adults with Down's syndrome. Am J Psychiatry 160 10 (2003) 1870-1878
55. Lai F., and Williams R.S. A prospective study of Alzheimer disease in Down syndrome. Arch Neurol 46 8 (1989) 849-853
56. Mann D.M., and Esiri M.M. The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome. J Neurol Sci 89 2-3 (1989) 169-179
57. Patterson D., Gardiner K., Kao F.T., et al. Mapping of the gene encoding the beta-amyloid precursor protein and its relationship to the Down syndrome region of chromosome 21. Proc Natl Acad Sci USA 85 21 (1988) 8266-8270
58. Krasuski J.S., Alexander G.E., Horwitz B., et al. Relation of medial temporal lobe volumes to age and memory function in nondemented adults with Down's syndrome: implications for the prodromal phase of Alzheimer's disease. Am J Psychiatry 159 1 (2002) 74-81
59. Teipel S.J., and Hampel H. Neuroanatomy of Down syndrome in vivo: a model of preclinical Alzheimer's disease. Behav Genet 36 3 (2006) 405-415
60. Wisniewski K.E., French J.H., Rosen J.F., et al. Basal ganglia calcification (BGC) in Down's syndrome (DS): another manifestation of premature aging. Ann N Y Acad Sci 396 (1982) 179-189
61. Takashima S., and Becker L.E. Basal ganglia calcification in Down's syndrome. J Neurol Neurosurg Psychiatr 48 1 (1985) 61-64
62. Verkerk A.J., Pieretti M., Sutcliffe J.S., et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65 5 (1991) 905-914
63. Mazzocco M.M., Kates W.R., Baumgardner T.L., et al. Autistic behaviors among girls with fragile X syndrome. J Autism Dev Disord 27 4 (1997) 415-435
64. Lachiewicz A.M., Gullion C.M., Spiridigliozzi G.A., et al. Declining IQs of young males with the fragile X syndrome. Am J Ment Retard 92 3 (1987) 272-278
65. Wright-Talamante C., Cheema A., Riddle J.E., et al. A controlled study of longitudinal IQ changes in females and males with fragile X syndrome. Am J Med Genet 64 2 (1996) 350-355
66. Mostofsky S.H., Mazzocco M.M., Aakalu G., et al. Decreased cerebellar posterior vermis size in fragile X syndrome: correlation with neurocognitive performance. Neurology 50 1 (1998) 121-130
67. Reiss A.L., Lee J., and Freund L. Neuroanatomy of fragile X syndrome: the temporal lobe. Neurology 44 7 (1994) 1317-1324
68. Jakala P., Hanninen T., Ryynanen M., et al. Fragile-X: neuropsychological test performance, CGG triplet repeat lengths, and hippocampal volumes. J Clin Invest 100 2 (1997) 331-338
69. Giedd J.N., Vaituzis A.C., Hamburger S.D., et al. Quantitative MRI of the temporal lobe, amygdala, and hippocampus in normal human development: ages 4-18 years. J Comp Neurol 366 2 (1996) 223-230
70. Eliez S., Blasey C.M., Freund L.S., et al. Brain anatomy, gender and IQ in children and adolescents with fragile X syndrome. Brain 124 Pt 8 (2001) 1610-1618
71. Giedd J.N., Snell J.W., Lange N., et al. Quantitative magnetic resonance imaging of human brain development: ages 4-18. Cereb Cortex 6 4 (1996) 551-560
72. Irwin S.A., Galvez R., and Greenough W.T. Dendritic spine structural anomalies in fragile-X mental retardation syndrome. Cereb Cortex 10 10 (2000) 1038-1044
73. Wisniewski K.E., Segan S.M., Miezejeski C.M., et al. The Fra(X) syndrome: neurological, electrophysiological, and neuropathological abnormalities. Am J Med Genet 38 2-3 (1991) 476-480
74. Greenough W.T., Klintsova A.Y., Irwin S.A., et al. Synaptic regulation of protein synthesis and the fragile X protein. Proc Natl Acad Sci USA 98 13 (2001) 7101-7106
75. Reiss A.L., Aylward E., Freund L.S., et al. Neuroanatomy of fragile X syndrome: the posterior fossa. Ann Neurol 29 1 (1991) 26-32
76. Courchesne E., Saitoh O., Yeung-Courchesne R., et al. Abnormality of cerebellar vermian lobules VI and VII in patients with infantile autism: identification of hypoplastic and hyperplastic subgroups with MR imaging. AJR Am J Roentgenol 162 1 (1994) 123-130
77. Courchesne E., Karns C.M., Davis H.R., et al. Unusual brain growth patterns in early life in patients with autistic disorder: an MRI study. Neurology 57 2 (2001) 245-254
78. Sears L.L., Vest C., Mohamed S., et al. An MRI study of the basal ganglia in autism. Prog Neuropsychopharmacol Biol Psychiatry 23 4 (1999) 613-624
79. Fu Y.H., Kuhl D.P., Pizzuti A., et al. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 67 6 (1991) 1047-1058
80. Rousseau F., Rouillard P., Morel M.L., et al. Prevalence of carriers of premutation-size alleles of the FMRI gene and implications for the population genetics of the fragile X syndrome. Am J Hum Genet 57 5 (1995) 1006-1018
81. Conway G.S., Payne N.N., Webb J., et al. Fragile X premutation screening in women with premature ovarian failure. Hum Reprod 13 5 (1998) 1184-1187
82. Hagerman R.J., Leehey M., Heinrichs W., et al. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology 57 1 (2001) 127-130
83. Loesch D.Z., Litewka L., Brotchie P., et al. Magnetic resonance imaging study in older fragile X premutation male carriers. Ann Neurol 58 2 (2005) 326-330
84. Greco C.M., Berman R.F., Martin R.M., et al. Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). Brain 129 Pt 1 (2006) 243-255
85. Cohen S., Masyn K., Adams J., et al. Molecular and imaging correlates of the fragile X-associated tremor/ataxia syndrome. Neurology 67 8 (2006) 1426-1431
86. Tezenas Du Montcel S., Mendizabai H., Ayme S., et al. Prevalence of 22q11 microdeletion. J Med Genet 33 8 (1996) 719
87. Shprintzen R.J., Goldberg R.B., Lewin M.L., et al. A new syndrome involving cleft palate, cardiac anomalies, typical facies, and learning disabilities: velo-cardio-facial syndrome. Cleft Palate J 15 1 (1978) 56-62
88. Gothelf D., Presburger G., Levy D., et al. Genetic, developmental, and physical factors associated with attention deficit hyperactivity disorder in patients with velocardiofacial syndrome. Am J Med Genet B Neuropsychiatr Genet 126 1 (2004) 116-121
89. Swillen A., Devriendt K., Legius E., et al. Intelligence and psychosocial adjustment in velocardiofacial syndrome: a study of 37 children and adolescents with VCFS. J Med Genet 34 6 (1997) 453-458
90. Swillen A., Devriendt K., Legius E., et al. The behavioural phenotype in velo-cardio-facial syndrome (VCFS): from infancy to adolescence. Genet Couns 10 1 (1999) 79-88
91. Feinstein C., Eliez S., Blasey C., et al. Psychiatric disorders and behavioral problems in children with velocardiofacial syndrome: usefulness as phenotypic indicators of schizophrenia risk. Biol Psychiatry 51 4 (2002) 312-318
92. Baker K.D., and Skuse D.H. Adolescents and young adults with 22q11 deletion syndrome: psychopathology in an at-risk group. Br J Psychiatry 186 (2005) 115-120
93. Chow E.W., Mikulis D.J., Zipursky R.B., et al. Qualitative MRI findings in adults with 22q11 deletion syndrome and schizophrenia. Biol Psychiatry 46 10 (1999) 1436-1442
94. Mitnick R.J., Bello J.A., and Shprintzen R.J. Brain anomalies in velo-cardio-facial syndrome. Am J Med Genet 54 2 (1994) 100-106
95. van Amelsvoort T., Daly E., Robertson D., et al. Structural brain abnormalities associated with deletion at chromosome 22q11: quantitative neuroimaging study of adults with velo-cardio-facial syndrome. Br J Psychiatry 178 (2001) 412-419
96. Shashi V., Muddasani S., Santos C.C., et al. Abnormalities of the corpus callosum in nonpsychotic children with chromosome 22q11 deletion syndrome. Neuroimage 21 4 (2004) 1399-1406
97. Scambler P.J. The 22q11 deletion syndromes. Hum Mol Genet 9 16 (2000) 2421-2426
98. Robin N.H., Taylor C.J., McDonald-McGinn D.M., et al. Polymicrogyria and deletion 22q11.2 syndrome: window to the etiology of a common cortical malformation. Am J Med Genet A 140 22 (2006) 2416-2425
99. Barkovich A.J., Rowley H., and Bollen A. Correlation of prenatal events with the development of polymicrogyria. AJNR Am J Neuroradiol 16 4 Suppl (1995) 822-827
100. Eliez S., Schmitt J.E., White C.D., et al. Children and adolescents with velocardiofacial syndrome: a volumetric MRI study. Am J Psychiatry 157 3 (2000) 409-415
101. Eliez S., Antonarakis S.E., Morris M.A., et al. Parental origin of the deletion 22q11.2 and brain development in velocardiofacial syndrome: a preliminary study. Arch Gen Psychiatry 58 1 (2001) 64-68
102. Kates W.R., Burnette C.P., Jabs E.W., et al. Regional cortical white matter reductions in velocardiofacial syndrome: a volumetric MRI analysis. Biol Psychiatry 49 8 (2001) 677-684
103. Kates W.R., Burnette C.P., Bessette B.A., et al. Frontal and caudate alterations in velocardiofacial syndrome (deletion at chromosome 22q11.2). J Child Neurol 19 5 (2004) 337-342
104. Simon T.J., Ding L., Bish J.P., et al. Volumetric, connective, and morphologic changes in the brains of children with chromosome 22q11.2 deletion syndrome: an integrative study. Neuroimage 25 1 (2005) 169-180
105. Reiss A.L., Faruque F., Naidu S., et al. Neuroanatomy of Rett syndrome: a volumetric imaging study. Ann Neurol 34 2 (1993) 227-234
106. Reiss A.L., Eliez S., Schmitt J.E., et al. Neuroanatomy of Williams syndrome: a high-resolution MRI study. J Cogn Neurosci 12 Suppl 1 (2000) 65-73
107. Simon T.J., Bish J.P., Bearden C.E., et al. A multilevel analysis of cognitive dysfunction and psychopathology associated with chromosome 22q11.2 deletion syndrome in children. Dev Psychopathol 17 3 (2005) 753-784
108. Eliez S., Blasey C.M., Menon V., et al. Functional brain imaging study of mathematical reasoning abilities in velocardiofacial syndrome (del22q11.2). Genet Med 3 1 (2001) 49-55
109. Shallice T., Fletcher P., Frith C.D., et al. Brain regions associated with acquisition and retrieval of verbal episodic memory. Nature 368 6472 (1994) 633-635
110. Eliez S., Blasey C.M., Schmitt E.J., et al. Velocardiofacial syndrome: are structural changes in the temporal and mesial temporal regions related to schizophrenia?. Am J Psychiatry 158 3 (2001) 447-453
111. Kates W.R., Miller A.M., Abdulsabur N., et al. Temporal lobe anatomy and psychiatric symptoms in velocardiofacial syndrome (22q11.2 deletion syndrome). J Am Acad Child Adolesc Psychiatry 45 5 (2006) 587-595
112. Debbane M., Schaer M., Farhoumand R., et al. Hippocampal volume reduction in 22q11.2 deletion syndrome. Neuropsychologia 44 12 (2006) 2360-2365
113. Schaer M., Schmitt J.E., Glaser B., et al. Abnormal patterns of cortical gyrification in velo-cardio-facial syndrome (deletion 22q11.2): an MRI study. Psychiatry Res 146 1 (2006) 1-11
114. Van Essen D.C. A tension-based theory of morphogenesis and compact wiring in the central nervous system. Nature 385 6614 (1997) 313-318
115. Barnea-Goraly N., Eliez S., Menon V., et al. Arithmetic ability and parietal alterations: a diffusion tensor imaging study in velocardiofacial syndrome. Brain Res Cogn Brain Res 25 3 (2005) 735-740
116. Eliez S., Schmitt J.E., White C.D., et al. A quantitative MRI study of posterior fossa development in velocardiofacial syndrome. Biol Psychiatry 49 6 (2001) 540-546
117. Bish J.P., Pendyal A., Ding L., et al. Specific cerebellar reductions in children with chromosome 22q11.2 deletion syndrome. Neurosci Lett 399 3 (2006) 245-248
118. Cohen I.L., Fisch G.S., Sudhalter V., et al. Social gaze, social avoidance, and repetitive behavior in fragile X males: a controlled study. Am J Ment Retard 92 5 (1988) 436-446
119. Golding-Kushner K.J., Weller G., and Shprintzen R.J. Velo-cardio-facial syndrome: language and psychological profiles. J Craniofac Genet Dev Biol 5 3 (1985) 259-266
120. Schmitt J.E., Eliez S., Warsofsky I.S., et al. Enlarged cerebellar vermis in Williams syndrome. J Psychiatr Res 35 4 (2001) 225-229
121. Campbell L.E., Daly E., Toal F., et al. Brain and behaviour in children with 22q11.2 deletion syndrome: a volumetric and voxel-based morphometry MRI study. Brain 129 Pt 5 (2006) 1218-1228
122. Chow E.W., Zipursky R.B., Mikulis D.J., et al. Structural brain abnormalities in patients with schizophrenia and 22q11 deletion syndrome. Biol Psychiatry 51 3 (2002) 208-215
123. Shenton M.E., Dickey C.C., Frumin M., et al. A review of MRI findings in schizophrenia. Schizophr Res 49 1-2 (2001) 1-52
124. van Amelsvoort T., Daly E., Henry J., et al. Brain anatomy in adults with velocardiofacial syndrome with and without schizophrenia: preliminary results of a structural magnetic resonance imaging study. Arch Gen Psychiatry 61 11 (2004) 1085-1096
125. Gothelf D., Eliez S., Thompson T., et al. COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome. Nat Neurosci 8 11 (2005) 1500-1502
126. Mattay V.S., Goldberg T.E., Fera F., et al. Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci USA 100 10 (2003) 6186-6191
127. Weis S., Weber G., Neuhold A., et al. Down syndrome: MR quantification of brain structures and comparison with normal control subjects. AJNR Am J Neuroradiol 12 6 (1991) 1207-1211
128. Frangou S., Aylward E., Warren A., et al. Small planum temporale volume in Down's syndrome: a volumetric MRI study. Am J Psychiatry 154 10 (1997) 1424-1429
129. Aylward E.H., Li Q., Habbak Q.R., et al. Basal ganglia volume in adults with Down syndrome. Psychiatry Res 74 2 (1997) 73-82
130. Eliez S., Barnea-Goraly N., Schmitt J.E., et al. Increased basal ganglia volumes in velo-cardio-facial syndrome (deletion 22q11.2). Biol Psychiatry 52 1 (2002) 68-70
131. Bish J.P., Nguyen V., Ding L., et al. Thalamic reductions in children with chromosome 22q11.2 deletion syndrome. Neuroreport 15 9 (2004) 1413-1415
132. Antshel K.M., Conchelos J., Lanzetta G., et al. Behavior and corpus callosum morphology relationships in velocardiofacial syndrome (22q11.2 deletion syndrome). Psychiatry Res 138 3 (2005) 235-245